KILITCH DRUGS INDIA LTD (KILITCH) financials — quarterly results, P&L, cash flow, balance sheet, shareholding

Incorporated in 1978, Kilitch Drugs Ltd is engaged in the operation and management of Pharmaceutical Products[1]

KILITCHUpdated 1 Sept 2026, 21:14

Kilitch Drugs India Ltd

Market Cap

₹595Cr.

Current Price

₹171

High / Low

₹220/117

Stock P/E

18.2

ROE9.49%
ROCE11.4%
Book Value₹95.2
Face Value₹10.0
Dividend Yield0.00%

About

Incorporated in 1978, Kilitch Drugs Ltd is engaged in the operation and management of Pharmaceutical Products[1]

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jun 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios
CategoryMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days24328520015088102120144165171168227
Inventory Days12411084393357343013226147
Days Payable1231521831083881127168180144188280
Cash Conversion Cycle244243101828378276-34940-6
Working Capital Days196230122984220-15-214255771
ROCE %-1%-2%-0%5%12%3%4%7%9%10%13%11%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 1 September 2026 at 21:14


Designed & Shipped by Harshit Bansal